RadNet, Inc. (RDNT) stock analysis
RDNT · RadNet, Inc.
Latest recorded price: USD 76.89
Model-estimated fair value: USD 7.61. This assumption-based estimate is for general research and is not investment advice.
Sector and industry: Healthcare · Diagnostics & Research
At $76.89, RDNT trades 910.9% above the model's base-case value of $7.61. Using Operating FCFF DCF (revenue x margin - reinvestment), the model estimates $3.98 in the conservative case and $11.95 in the optimistic case, with a valuation confidence score of 91/100. Fiscal 2025 figures: revenue growth 12.6%, free cash flow margin 4.2%, ROIC 2.9%. The model does not flag any risk signals for this company.